Rankings
▼
Calendar
JBIO Q2 2024 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
JBIO
Jade Biosciences, Inc.
$491M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$28,000
Operating Income
-$26M
Net Income
-$25M
EPS (Diluted)
$-30.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$112M
Total Liabilities
$17M
Stockholders' Equity
$94M
Cash & Equivalents
$31M
← FY 2024
All Quarters
Q3 2024 →